Hepatic and Extrahepatic Malignancies in Primary Biliary Cirrhosis
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Hepatocellular carcinoma (HCC) is rarely reported as a complication of primary biliary cirrhosis (PBC). However, data suggest that patients with PBC have an increased incidence of breast cancer when compared with the general population. Our aim was to analyze the incidence of malignancies in a large series of PBC patients from North–East Italy; to compare findings with those obtained in the general population of the same geographical area, as derived from the general cancer registry; and to study any possible adjunctive risk factor for malignancy. The overall sample included 175 patients (9 males, 166 females). The mean age at presentation was 50.8 years (range 23–77); 17 patients had histological stage I, 45 had stage II, 76 had stage III, and 37 had stage IV. The prevalence of gynecological diseases obtained from the past history of the females included 19.9% miscarriages, 12% hysterectomies, and 2.4% curettages. The follow–up period was 1,187 person/years (average 6.8 yrs per person as a mean). The comparison of the incidence of malignancies between the study group and the general population was obtained by the proportional incidence ratio (PIR), which is the ratio between the cases observed and the expected number of cases in the study group. Logistic regression analysis was performed utilizing the risk factors significantly associated with cancer development in the univariate analysis. Extrahepatic malignancies developed in eight cases (4.5%) and HCC in a further four cases (2.3%), all associated with cirrhosis. Two of the four patients with HCC had a superinfection with hepatitis C virus (HCV). Breast cancer developed only in two patients. The PIR for HCC was 26.27 (95% CI 6.8–46.5), whereas the PIR for breast cancer was 0.43. The logistic regression analysis indicated that a history of cigarette smoking and HCV–RNA positivity were independent variables for the development of HCC. HCC has a relatively high prevalence in PBC and HCV superinfection may play an important part in favoring HCC. The incidence of breast cancer is not significantly higher in PBC than in the general population of the same area
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes
Jones, D. E., Metcalf, J. V., Collier, J. D., Bassendine, M. F., & James, O. F. (1997) · Hepatology · doi:10.1002/hep.510260508 · Cited by 161
Cited by
Hepatocellular carcinoma and survival in patients with primary biliary cirrhosis
Shibuya, A., Tanaka, K., Miyakawa, H., Shibata, M., Takatori, M., Sekiyama, K., Hashimoto, N., Amaki, S., Komatsu, T., & Morizane, T. (2002) · Hepatology · doi:10.1053/jhep.2002.33157 · Cited by 116
Cavazza, A., Caballería, L., Floreani, A., Farinati, F., Bruguera, M., Caroli, D., & Parés, A. (2009) · Hepatology · doi:10.1002/hep.23095 · Cited by 114
Self-citationSurveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis
Silveira, M. G., Suzuki, A., & Lindor, K. D. (2008) · Hepatology · doi:10.1002/hep.22458 · Cited by 68
Clinical predictors for hepatocellular carcinoma in patients with primary biliary cirrhosis
Suzuki, A., Lymp, J., Donlinger, J., Mendes, F., Angulo, P., & Lindor, K. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.031 · Cited by 57
Natarajan, Y., Tansel, A., Patel, P., Emologu, K., Shukla, R., Qureshi, Z., El-Serag, H. B., Thrift, A. P., & Kanwal, F. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06498-7 · Cited by 49
Tomiyama, Y., Takenaka, K., Kodama, T., Kawanaka, M., Sasaki, K., Nishina, S., Yoshioka, N., Hara, Y., & Hino, K. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.0010 · Cited by 35
Metadata
- Authors
- Floreani, A., Baragiotta, A., Baldo, V., Menegon, T., Farinati, F., & Naccarato, R.
- Venue
- Hepatology
- Published
- 1999-05
- Volume
- 29
- Issue
- 5
- Pages
- 1425-1428
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1999938910
- Cited by
- 74
- References
- 1
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.